FOLH1 and neoplasm: Covalent binding of vector molecules (PSMA) for further radiolabeling in the final step of synthetic processes to the SPIONs provides a precise, targeted delivery of obtained radiobioconjugate only to the selected tumor cells overexpressing PSMA receptors, while the external alternating magnetic field causing an increase temperature multiplies the therapeutic effect.